Caris Diagnostics Announces Name Change to Miraca Life Sciences
"The new name is a logical step as we complete the successful ownership transition of this world-class diagnostics organization," said Takeo Hayashi, Chairman and CEO of the newly-named Miraca Life Sciences. "While the name has changed, the fundamental value proposition has not: a unique, high quality pathology practice with an abiding commitment to diagnostic excellence and improved patient care."
Since 2005, Caris Diagnostics has established an unprecedented reputation among clinicians by creating an innovative, best-in-class practice that results in improved patient care. The word "Miraca" is a combination of the Japanese words 'future' and 'science', so the new corporate name is a natural fit for the company's mission and Miraca's global network of employees, clinicians and patients.